Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
NCT ID: NCT05905016
Last Updated: 2026-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2021-10-01
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endoscopic Peroral Myotomy for Treatment of Achalasia
NCT01405417
GI Neuromuscular Pathology Prospective Registry
NCT02165059
Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia
NCT05899842
Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia
NCT02073578
Esophageal Motility Disorders in Patients With Non-cardiac Chest Pain at Assiut University Hospital
NCT05402462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will enroll 600 subjects over the next 4 to 5 years.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Esophageal POEM
Data will be collected for patients under going standard of care Esophageal POEM (E-POEM)
No interventions assigned to this group
Gastric POEM
Data will be collected for patients under going standard of care Gastric POEM (G-POEM)
No interventions assigned to this group
Zenker's POEM
Data will be collected for patients under going standard of care Zenker's diverticulum POEM (Z-POEM)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Scheduled to undergo POEM
Exclusion Criteria
2. Participation in another research protocol that could interfere or influence the outcomes measures of the present study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AdventHealth
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dennis Yang, MD
Role: PRINCIPAL_INVESTIGATOR
AdventHealth Orlando
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AdventHealth Orlando
Orlando, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1798543
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.